Next generation ophthalmic surgical platform given EU approval.
Bausch & Lomb has announced that it has received CE Mark from the European Commission for the Stellaris Elite Vision Enhancement System, the company's next generation ophthalmic surgical platform, which includes Vitesse, the first and only hypersonic, open-port vitrectomy system.The Stellaris Elite platform is now available throughout greater Europe, including the 28 countries of the European Union, Iceland, Liechtenstein, Norway and Switzerland.
Already available in the United States on 19 April 2017, the Stellaris Elite Vision Enhancement System is the first phacoemulsification platform to offer Adaptive Fluidics, which combines precise aspiration control with predictive infusion management to create a highly responsive and controlled surgical environment for efficient lens removal. As part of the platform's vitreoretinal capabilities, the Vitesse hypersonic vitrectomy system uses a novel, single-needle design and continuously open-port system that represents the first major advancement in vitreous removal in 40 years. Vitesse will be available exclusively on the Stellaris Elite platform.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
1 mins